Klotho Neurosciences, Inc. Common Stock (KLTO)
Klotho Neurosciences, Inc. is a biotechnology company focused on developing therapies targeting neurodegenerative diseases. The company aims to leverage its proprietary research in neurobiology to create innovative treatments for conditions such as Alzheimer's and other age-related cognitive disorders.
Company News
Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets
Klotho Neurosciences has partnered with AAVnerGene to enhance gene therapy manufacturing processes for neurological disease treatments, focusing on more efficient and cost-effective AAV vector technologies.
Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco
Klotho Neurosciences, a biotechnology company focused on developing cell and gene therapies for neurodegenerative diseases, will present at the Biotech Showcase 2025 conference during the J.P. Morgan Healthcare Week in San Francisco.